When administered, Ozempic binds to GLP-1 receptors in multiple areas of the body, including the pancreas, gastrointestinal tract, and importantly, the hypothalamusthe brain region responsible for regulating hunger and satiety
(NYSE: HIMS) today announced that a broad assortment of Novo Nordisks FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy pill, which is the only FDA-approved GLP-1 weight loss pill
CDSCO flags GLP-1 obesity campaigns Compliance requirements The ministry further requires all manufacturers, importers, and marketing authorization holders to ensure strict compliance with the Drugs and Cosmetics Act, 1940 and Rules made thereunder
If you have any issues or questions, please reach out to your doctor through our support platform